Texas Permanent School Fund’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,419
Closed -$373K 1519
2023
Q2
$373K Sell
17,419
-188
-1% -$4.02K ﹤0.01% 1478
2023
Q1
$712K Buy
17,607
+4,510
+34% +$182K 0.01% 1342
2022
Q4
$609K Sell
13,097
-919
-7% -$42.7K 0.01% 1295
2022
Q3
$727K Buy
14,016
+692
+5% +$35.9K 0.01% 1230
2022
Q2
$630K Buy
13,324
+385
+3% +$18.2K 0.01% 1293
2022
Q1
$921K Sell
12,939
-31
-0.2% -$2.21K 0.01% 1229
2021
Q4
$970K Sell
12,970
-339
-3% -$25.4K 0.01% 1227
2021
Q3
$756K Sell
13,309
-85
-0.6% -$4.83K 0.01% 1302
2021
Q2
$589K Sell
13,394
-19
-0.1% -$836 0.01% 1383
2021
Q1
$662K Sell
13,413
-936
-7% -$46.2K 0.01% 1331
2020
Q4
$604K Sell
14,349
-2,338
-14% -$98.4K 0.01% 1329
2020
Q3
$764K Buy
16,687
+3,885
+30% +$178K 0.01% 1212
2020
Q2
$643K Sell
12,802
-757
-6% -$38K 0.01% 1215
2020
Q1
$697K Buy
13,559
+2,630
+24% +$135K 0.01% 1101
2019
Q4
$675K Buy
10,929
+78
+0.7% +$4.82K 0.01% 1234
2019
Q3
$652K Buy
10,851
+38
+0.4% +$2.28K 0.01% 1234
2019
Q2
$912K Buy
10,813
+120
+1% +$10.1K 0.01% 1105
2019
Q1
$1.02M Buy
10,693
+397
+4% +$37.9K 0.02% 1068
2018
Q4
$729K Buy
10,296
+420
+4% +$29.7K 0.01% 1150
2018
Q3
$844K Buy
9,876
+549
+6% +$46.9K 0.01% 1181
2018
Q2
$1.08M Sell
9,327
-182
-2% -$21.1K 0.01% 1079
2018
Q1
$769K Sell
9,509
-142
-1% -$11.5K 0.01% 1187
2017
Q4
$566K Sell
9,651
-772
-7% -$45.3K 0.01% 1306
2017
Q3
$488K Buy
10,423
+277
+3% +$13K 0.01% 1360
2017
Q2
$365K Buy
10,146
+85
+0.8% +$3.06K ﹤0.01% 1412
2017
Q1
$310K Sell
10,061
-74
-0.7% -$2.28K ﹤0.01% 1429
2016
Q4
$340K Sell
10,135
-451
-4% -$15.1K ﹤0.01% 1428
2016
Q3
$282K Buy
10,586
+439
+4% +$11.7K ﹤0.01% 1435
2016
Q2
$224K Sell
10,147
-419
-4% -$9.25K ﹤0.01% 1452
2016
Q1
$310K Sell
10,566
-297
-3% -$8.71K ﹤0.01% 1401
2015
Q4
$359K Buy
10,863
+34
+0.3% +$1.12K ﹤0.01% 1385
2015
Q3
$391K Buy
+10,829
New +$391K 0.01% 1369